# Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir

> **NCT05108051** · PHASE1 · COMPLETED · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 36 (actual)

## Conditions studied

- Drug-drug Interaction

## Interventions

- **DRUG:** ZSP1273
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT05108051
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-19
- **Primary completion:** 2021-03-17
- **Final completion:** 2021-03-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05108051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05108051, "Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05108051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*